Chongqing Taiji Industry Group Co Ltd: A Comprehensive Overview

Chongqing Taiji Industry (Group) Co., Ltd., a prominent player in the health care sector, specializes in the pharmaceutical industry. Based in Chongqing, China, the company is renowned for its extensive range of products, including medicines, healthcare products, medical packaging products, and medical instruments. Additionally, Chongqing Taiji Industry is involved in the import and export of Chinese medicine materials and medical packaging materials, further solidifying its position in the global market.

The company’s stock is actively traded on the Shanghai Stock Exchange, reflecting its significant presence in the financial markets. As of July 31, 2025, the close price of the stock was recorded at 25.18 CNH. Over the past year, the stock has experienced fluctuations, reaching a 52-week high of 30.86 on October 7, 2024, and a 52-week low of 18.7 on February 4, 2025. Despite these variations, the company maintains a substantial market capitalization of 13,470,000,000 CNH.

Chongqing Taiji Industry’s financial metrics indicate a challenging period, with a price-to-earnings ratio of -55.48. This negative ratio suggests that the company has faced difficulties in generating profits, which may be attributed to various market conditions or internal factors. Nonetheless, the company continues to operate and innovate within the pharmaceutical sector.

The company’s journey began with its initial public offering (IPO) on October 22, 1997, marking its entry into the public market. Since then, Chongqing Taiji Industry has expanded its operations and product offerings, maintaining a focus on quality and innovation.

For more detailed information about Chongqing Taiji Industry Group Co., Ltd., including its product offerings and corporate updates, interested parties can visit the company’s official website at www.iji.com .

In summary, Chongqing Taiji Industry Group Co., Ltd. remains a key player in the pharmaceutical industry, navigating market challenges while continuing to provide a diverse range of health care products and services.